Newly Approved Drug Therapies (666) Reminyl (galantamine hydrobromide), Janssen Pharmaceutica, The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.Reminyl is an Alzheimer s treatment derived from the bulbs of the daffodil, Narcissus pseudonarcissus. It is believed that neurons producing the neurotransmitter acetylcholine degenerate in the brains of patients with Alzheimer s disease. This loss of acetylcholine has been correlated with decreased cognitive function (thinking, remembering and reasoning). Reminyl works to increase the concentration of acetylcholine by blocking the action of acetylcholinesterase, an enzyme that catalyzes the hydrolysis (break down) of acetylcholine.
